Michael  Stubblefield net worth and biography

Michael Stubblefield Biography and Net Worth

President, CEO & Director of Avantor
Michael Stubblefield is our President and CEO, a position he has held since May 2014. Prior to assuming his current position, Mr. Stubblefield served as a Senior Expert for Chemicals Practice of McKinsey & Company from 2013 to 2014. Prior to this role, Mr. Stubblefield held a variety of roles at Celanese Corporation from 1994 to 2012, including Vice President and General Manager, Advanced Engineered Materials and Chief Marketing Officer. Mr. Stubblefield earned a bachelor’s degree in chemical engineering from the University of Utah, as well as an MBA from Texas A&M University-Corpus Christi.

What is Michael Stubblefield's net worth?

The estimated net worth of Michael Stubblefield is at least $7.03 million as of November 16th, 2022. Mr. Stubblefield owns 429,500 shares of Avantor stock worth more than $7,027,479 as of March 26th. This net worth estimate does not reflect any other assets that Mr. Stubblefield may own. Additionally, Mr. Stubblefield receives an annual salary of $1,360,000.00 as President, CEO & Director at Avantor. Learn More about Michael Stubblefield's net worth.

How old is Michael Stubblefield?

Mr. Stubblefield is currently 51 years old. There are 7 older executives and no younger executives at Avantor. Learn More on Michael Stubblefield's age.

What is Michael Stubblefield's salary?

As the President, CEO & Director of Avantor, Inc., Mr. Stubblefield earns $1,360,000.00 per year. Learn More on Michael Stubblefield's salary.

How do I contact Michael Stubblefield?

The corporate mailing address for Mr. Stubblefield and other Avantor executives is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. Avantor can also be reached via phone at (610) 386-1700 and via email at avantorir@avantorsciences.com. Learn More on Michael Stubblefield's contact information.

Has Michael Stubblefield been buying or selling shares of Avantor?

Michael Stubblefield has not been actively trading shares of Avantor during the past quarter. Most recently, on Wednesday, November 16th, Michael Stubblefield bought 15,000 shares of Avantor stock. The stock was acquired at an average cost of $20.95 per share, with a total value of $314,250.00. Following the completion of the transaction, the chief executive officer now directly owns 429,500 shares of the company's stock, valued at $8,998,025. Learn More on Michael Stubblefield's trading history.

Who are Avantor's active insiders?

Avantor's insider roster includes James Bramwell (EVP), Gerard Brophy (EVP), Christophe Couturier (EVP), Steven Eck (CAO), Rajiv Gupta (Director), Justin Miller (EVP), Jo Natauri (Director), Devashish Ohri (EVP), Christi Shaw (Director), Michael Stubblefield (President, CEO & Director), Thomas Szlosek (CFO), Frederic Vanderhaegen (EVP), and Michael Wondrasch (EVP). Learn More on Avantor's active insiders.

Are insiders buying or selling shares of Avantor?

In the last twelve months, insiders at the sold shares 3 times. They sold a total of 12,190 shares worth more than $240,233.95. The most recent insider tranaction occured on February, 26th when EVP James Bramwell sold 3,758 shares worth more than $65,877.74. Insiders at Avantor own 1.5% of the company. Learn More about insider trades at Avantor.

Information on this page was last updated on 2/26/2025.

Michael Stubblefield Insider Trading History at Avantor

See Full Table

Michael Stubblefield Buying and Selling Activity at Avantor

This chart shows Michael Stubblefield's buying and selling at Avantor by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200k$0$200kTotal Insider BuyingTotal Insider Selling

Avantor Company Overview

Avantor logo
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Read More

Today's Range

Now: $16.36
Low: $16.25
High: $16.44

50 Day Range

MA: $18.76
Low: $15.50
High: $22.60

2 Week Range

Now: $16.36
Low: $15.37
High: $28.00

Volume

56,877 shs

Average Volume

6,302,783 shs

Market Capitalization

$11.14 billion

P/E Ratio

15.72

Dividend Yield

N/A

Beta

1.3